Skip to main content
Premium Trial:

Request an Annual Quote

Just to Know

At the time that the Human Genome Project was going on, many people knew that it was being oversold, writes Jonathan Eisen at The Tree of Life. (He adds that he wished he had a blog at the time so he could have given it his "Overselling Genomics Award.") And so, he's not surprised at the current "backlash" against the project — he rounds up some recent stories that say that the project hasn't lived up to its expectations. "The problem here is that the human genome project should never have been sold as a means to a series of practical ends. It should have been sold as a massive basic science project, much like going to the moon or building a giant linear accelerator," Eisen writes. "That is, the human genome project was, and still really is, about knowledge. It is about knowing ourselves."

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.